Nonetheless, understanding the potential for estrogen regulation of components of cytokine networks and the extracellular matrix in the individual cell types illustrates candidate pathways that may underlie responses to estrogen agonists and anti-estrogens in ER+ breast cancer, and are worthy of additional study. This evidence concerns the gene ESR1 and breast carcinoma.